BROWSE

Related Scientist

Researcher

안정은
유전체 항상성 연구단
more info

Functions of TET Proteins in Hematopoietic Transformation

DC Field Value Language
dc.contributor.authorHan, JA-
dc.contributor.authorJungeun An-
dc.contributor.authorKo, M-
dc.date.available2016-02-22T09:01:33Z-
dc.date.created2016-01-22-
dc.date.issued2015-11-
dc.identifier.issn1016-8478-
dc.identifier.urihttps://pr.ibs.re.kr/handle/8788114/2388-
dc.description.abstractDNA methylation is a well-characterized epigenetic modification that plays central roles in mammalian development, genomic imprinting, X-chromosome inactivation and silencing of retrotransposon elements. Aberrant DNA methylation pattern is a characteristic feature of cancers and associated with abnormal expression of oncogenes, tumor suppressor genes or repair genes. Ten-eleven-translocation (TET) proteins are recently characterized dioxygenases that catalyze progressive oxidation of 5-methylcytosine to produce 5-hydroxymethylcytosine and further oxidized derivatives. These oxidized methylcytosines not only potentiate DNA demethylation but also behave as independent epigenetic modifications per se. The expression or activity of TET proteins and DNA hydroxymethylation are highly dysregulated in a wide range of cancers including hematologic and non-hematologic malignancies, and accumulating evidence points TET proteins as a novel tumor suppressor in cancers. Here we review DNA demethylation-dependent and -independent functions of TET proteins. We also describe diverse TET loss-of-function mutations that are recurrently found in myeloid and lymphoid malignancies and their potential roles in hematopoietic transformation. We discuss consequences of the deficiency of individual Tet genes and potential compensation between different Tet members in mice. Possible mechanisms underlying facilitated oncogenic transformation of TET-deficient hematopoietic cells are also described. Lastly, we address non-mutational mechanisms that lead to suppression or inactivation of TET proteins in cancers. Strategies to restore normal 5mC oxidation status in cancers by targeting TET proteins may provide new avenues to expedite the development of promising anti-cancer agents. (c) The Korean Society for Molecular and Cellular Biology.-
dc.languageENG-
dc.publisherKOREAN SOC MOLECULAR & CELLULAR BIOLOGY-
dc.titleFunctions of TET Proteins in Hematopoietic Transformation-
dc.typeArticle-
dc.type.rimsA-
dc.identifier.wosid000366741300001-
dc.identifier.scopusid2-s2.0-84975299107-
dc.description.wostc8-
dc.date.tcdate2018-10-01-
dc.date.scptcdate2018-10-01-
dc.subject.keyword5-methylcytosine oxidation-
dc.subject.keywordhematopoiesis-
dc.subject.keywordhematologic malignancies-
dc.subject.keywordTET protein-
dc.subject.keywordtumor suppression-
dc.contributor.affiliatedAuthorJungeun An-
dc.identifier.bibliographicCitationMOLECULES AND CELLS, v.38, no.11, pp.925 - 935-
dc.description.scptc8-
Appears in Collections:
Center for Genomic Integrity(유전체 항상성 연구단) > Journal Papers (저널논문)
Files in This Item:
Functions of TET Proteins in Hematopoietic Transformation.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse